Perlmann P, Perlmann H, ElGhazali G, Blomberg M T
Department of Immunology, Stockholm University, Sweden.
Immunol Lett. 1999 Jan;65(1-2):29-33. doi: 10.1016/s0165-2478(98)00120-5.
IgE, the immunoglobulin instrumental in atopic diseases is also elevated in many infections. This paper reports on the occurrence and possible pathogenic role of IgE in human Plasmodium falciparum malaria, one of the most widely spread and severe infectious diseases world wide. Plasmodial infections induce IgE elevation in the blood of the majority of people living in malaria endemic areas and up to 5% of this IgE constitutes anti-malaria antibodies. Production of IgE is controlled by T cells and elevated IgE concentrations in the blood of malaria patients are the result of an increased ratio of T-helper 2 (Th2) over T-helper 1 (Th1) cells. The underlying Th1 to Th2 switch is controlled by a variety of environmental and genetic factors. The importance of the latter is demonstrated by the IgE levels occurring in monozygotic or dizygotic twins originating from malarious areas of Africa. While these levels were indistinguishable within monozygotic twin pairs, they were different within the dizygotic pairs. Comparison of the levels of total IgE or IgE anti-malaria antibodies in patients with uncomplicated malaria with those in patients with the severe form of the disease (cerebral malaria or severe malaria without cerebral involvement) indicate that these levels are significantly higher in the cases with severe disease. This is the reverse with IgG and suggests that IgE plays a role in malaria pathogenesis. An important pathogenic mediator causing malaria fever and tissue lesions is tumor necrosis factor (TNF), generally believed to be induced by toxins released from the parasite. However, sera from malaria patients can also cause TNF release from monocytes in a reaction dependent on the presence of IgE containing immune complexes or aggregates. This results in induction and cross-linking of Fcepsilon receptor II (CD23) and by binding to and activating these cells, IgE will contribute to a local over-production of TNF in capillaries and post-capillary venules where P. falciparum parasites or their products accumulate in the severe forms of this disease.
IgE 这种在特应性疾病中起作用的免疫球蛋白,在许多感染中也会升高。本文报道了 IgE 在人类恶性疟原虫疟疾(全球传播最广且最严重的传染病之一)中的发生情况及其可能的致病作用。疟原虫感染会使大多数生活在疟疾流行地区的人的血液中 IgE 升高,其中高达 5% 的 IgE 构成抗疟疾抗体。IgE 的产生受 T 细胞控制,疟疾患者血液中 IgE 浓度升高是辅助性 T 细胞 2(Th2)与辅助性 T 细胞 1(Th1)细胞比例增加的结果。潜在的 Th1 向 Th2 的转变受多种环境和遗传因素控制。后者的重要性通过源自非洲疟疾流行地区的单卵双胞胎或双卵双胞胎的 IgE 水平得以体现。虽然这些水平在单卵双胞胎对中无差异,但在双卵双胞胎对中则不同。比较无并发症疟疾患者与重症疟疾(脑型疟疾或无脑部受累的重症疟疾)患者的总 IgE 或抗疟疾 IgE 抗体水平,结果表明重症患者的这些水平显著更高。这与 IgG 情况相反,提示 IgE 在疟疾发病机制中起作用。一种导致疟疾发热和组织损伤的重要致病介质是肿瘤坏死因子(TNF),通常认为它是由寄生虫释放的毒素诱导产生的。然而,疟疾患者的血清在依赖含 IgE 的免疫复合物或聚集体存在的反应中也能导致单核细胞释放 TNF。这会导致 Fcε受体 II(CD23)的诱导和交联,通过结合并激活这些细胞,IgE 将促使在恶性疟原虫寄生虫或其产物在该疾病重症形式中积聚的毛细血管和毛细血管后微静脉中局部过量产生 TNF。